Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis - A clinical study using myocardial T1-mapping and extracellular volume quantification

Journal of Cardiovascular Magnetic Resonance

Volumn 16, Issue 1, 2014, Pages

  Ntusi, Ntobeko Ab ^a   Piechnik, Stefan K ^a   Francis, Jane M ^a   Ferreira, Vanessa M ^a   Rai, Aitzaz Bs ^a   Matthews, Paul M ^b,c   Robson, Matthew D ^a   Moon, James ^d   Wordsworth, Paul B ^e   Neubauer, Stefan ^a   Karamitsos, Theodoros D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance; Extracellular volume estimation; Gadolinium; Scleroderma; T1 mapping

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CHRONICITY; CLINICAL ARTICLE; CLINICAL STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; EXTRACELLULAR SPACE; FEMALE; HEART MUSCLE FIBROSIS; HUMAN; MALE; MYOCARDITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMIC SCLEROSIS;

AGED; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CONTRAST MEDIA; DIASTOLE; EDEMA, CARDIAC; ENGLAND; FEMALE; FIBROSIS; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SCLERODERMA, DIFFUSE; SEVERITY OF ILLNESS INDEX; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84899500053     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/1532-429X-16-21     Document Type: Article

References (45)

1. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Steen VD, Medsger TA Jr, Arthritis Rheum 2000 43 2437 44 10.1002/1529- 0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U 11083266
2. Uber ein eigenartiges Krankheitsbild von deiffuser Sklerosis der haut and inner organe (Peculiar disease profile of diffuse sclerosis of the skin and inner organs). Heine J, Virchows Arch 1926 262 1 10.1007/BF01994967
3. The heart is scleroderma. Champion HC, Rheum Dis Clin North Am 2008 34 181 90 10.1016/j.rdc.2007.12.002 18329539
4. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. Follansbee WP, Curtis EI, Medsger TA Jr, Steen VD, Uretsky BF, Owens GR, Rodnan GP, N Eng J Med 1984 310 142 8 10.1056/NEJM198401193100302
5. Cardiac score: a semiquantitative measure of cardiac involvement that improves prediction of prognosis in systemic sclerosis. Clements PJ, Lachenbruch PA, Furst DE, Paulus HE, Sterz MG, Arthritis Rheum 1991 34 1371 80 1835389
6. Primary myocardial involvement in systemic sclerosis. Kahan A, Allanore Y, Rheumatology 2006 45 Suppl. 4 14 7
7. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. D'Angelo WA, Fries JF, Masi AT, Shulman LE, Am J Med 1969 46 428 40 10.1016/0002-9343(69)90044-8 5780367
8. Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction. Bulkley BH, Ridolfi RL, Salyer WR, Hutchins GM, Circulation 1976 53 483 90 10.1161/01.CIR.53.3.483 1248080
9. The microvascular endothelium in scleroderma. Kahaleh B, Rheumatology 2008 47 Suppl 5 14 5
10. The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of cardiology and the European Society of Cardiology. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R, Eur Heart J 2007 28 3076 93 10.1093/eurheartj/ehm456 17959624
11. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Hachulla AL, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P, Hatron PY, Beregi JP, Hachulla E, Ann Rheum Dis 2009 68 1878 84 10.1136/ard.2008.095836 19054830
12. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, Gialafos EJ, Moyssakis I, Moutsopoulos HM, Arthritis Rheum 2007 56 3827 36 10.1002/art.22971 17968945
13. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, Aletras A, Laissy JP, Paterson I, Filipchuk NG, Kumar A, Pauschinger M, Liu P, International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis, J Am Coll Cardiol 2009 53 1475 87 10.1016/j.jacc.2009.02.007 19389557
14. T1 mapping for the diagnosis of acute myocarditis using cardiovascular magnetic resonance-comparison to T2-weighted and late gadolinium enhanced imaging. Ferreira VM, Piechnick SK, Dall'Armellina E, Karamitsos TD, Francis JM, Ntusi N, Holloway C, Choudhury RP, Kardos A, Robson MD, Friedrich MG, Neubauer S, J Am Coll Cardiol Cardiovasc Imaging 2013 doi:pii:S1936-878X(13)00539-1.10- 1016/jcmg.2013.03.008. Epub ahead off print
15. Noninvasive imaging of myocardial extracellular matrix for assessment of fibrosis. Won S, Davies-Venn C, Liu S, Bleumke DA, Curr Opin Cardiol 2013 28 282 9 10.1097/HCO.0b013e32835f5a2b 23549230
16. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. Mewton N, Liu CY, Croiselle P, Bluemke D, Lima JA, J Am Coll Cardiol 2011 57 891 903 10.1016/j.jacc.2010.11.013 21329834
17. Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. Ferreira VM, Piechnik SK, Dall'Armellina E, Karamitsos TD, Francis JM, Choudhury RP, Friedrich MG, Robson MD, Neubauer S, J Cardiovasc Magn Reson 2012 14 42 10.1186/1532-429X-14-42 22720998
18. Modified Look-Locker Inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivanantham MU, Ridgway JP, Magn Res Med 2004 52 141 6 10.1002/mrm.20110
19. Shortened Modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 And 3T within a 9 heartbeath breathhold. Piechnik S, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S, Robson MD, J Cardiovasc Magn Res 2010 12 69 10.1186/1532-429X-12-69
20. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. Iles L, Pfluger H, Phrommintikul A, Cherayath J, Aksit P, Gupta SN, Kaye DM, Taylor AJ, J Am Coll Cardiol 2008 52 1574 80 10.1016/j.jacc.2008.06.049 19007595
21. Human non-contrast T1 values and correlation with histology in diffuse fibrosis. Bull S, White SK, Piechnik SK, Flett AS, Ferreira VM, Loudon M, Francis JM, Karamitsos TD, Prendegrast BD, Robson MD, Neubauer S, Moon JC, Myerson SG, Heart 2013 99 932 7 10.1136/heartjnl-2012-303052 23349348
22. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, Arthritis Rheum 1980 23 581 90 10.1002/art.1780230510 7378088
23. Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage. Payne AR, Casey M, McClure J, McGeoch R, Murphy A, Woodward R, Saul A, Bi X, Zeuhlsdorff S, Oldroyd KG, Tzemos N, Berry C, Circ Cardiovasc Imaging 2011 4 210 9 10.1161/CIRCIMAGING.110.960450 21427362
24. Two-dimensional left ventricular deformation during systole using magnetic resonance imaging with spatial modulation of magnetization. Young AA, Imai H, Cheng-Ning C, Axel L, Circulation 1994 89 740 52 10.1161/01.CIR.89.2.740 8313563
25. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Kellman P, Arai AE, McVeigh ER, Aletras AH, Magn Reson Med 2002 47 372 83 10.1002/mrm.10051 11810682
26. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, Piechnik SK, Robson MD, Hausenloy DJ, Sheikh AM, Hawkins PN, Moon JC, J Am Coll Cardiol Cardiovasc Imaging 2013 doi:pii:S1936-878X(13)00229-5. 10.1016/j.jcmg.2013.01.011. Epub ahead of print
27. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Jerosh-Herold M, Sheridan DC, Kushner JD, Nauman D, Burgess D, Dutton D, Alharethi R, Li D, Hershberger RE, Am J Physiol Heart Circ Physiol 2008 295 Suppl H 1234 42 18660445
28. Role of transcytolemmal water-exchange in magnetic resonance measurements of diffuse myocardial fibrosis in hypertensive disease. Coelho-Filho OR, Mongeon FP, Mitchell R, Moreno H Jr, Nadrz W Jr, Kwong R, Jerosch-Herold M, Circ Cardiovasc Imaging 2013 6 134 41 10.1161/CIRCIMAGING.112.979815 23159497
29. European multicenter study to define disease activity criteria for systemic sclerosis. Identification of disease activity variables and development of preliminary activity indexes. Valentini G, Della Rossa A, Bombardieri S, Bencivelli W, Silman AJ, D'Angelo S, Cerinic MM, Belch JF, Black CM, Bruhlmann P, Czirjak L, de Luca A, Drosos AA, Ferri C, Gabrielli A, Giacomelli R, Hayem G, Inanc M, McHugh NJ, Nielsen H, Rosada M, Scorza R, Stork J, Sysa A, van den Hoogen FH, Vlachoyiannopoulos PJ, Ann Rheum Dis 2001 60 592 8 10.1136/ard.60.6.592 11350848
30. Inter and intraobserver variability of total skin thickness core (modified Rodnan TSS) in systemic sclerosis. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D, Wigley F, Medsger T Jr, Steen V, Moreland L, Dixon M, Massa M, Lally E, McCloskey D, Varga J, J Rheumatol 1995 22 1281 5 7562759
31. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI, Circ Res 1988 62 757 65 10.1161/01.RES.62.4.757 2964945
32. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P, Circulation 1994 89 151 63 10.1161/01.CIR.89.1.151 8281642
33. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. Ling LH, Kistler PM, Ellims AH, Iles LM, Lee G, Hughes GL, Kalman JM, Kaye DM, Taylor AJ, J Am Coll Cardiol 2012 60 2402 8 10.1016/j.jacc.2012.07.065 23141493
34. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. Dall'Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM, Cuculi F, Kharbanda RK, Banning AP, Choudhury RP, Karamitsos TD, Neubauer S, J Cardiovasc Magn Res 2012 15 15
35. Non-contrast T1 mapping for the diagnosis of cardiac amyloidosis. Karamitsos TD, Piechnik SK, Banypersad SM, Fontana M, Ntusi NB, Ferreira VM, Whelan CJ, Myerson SG, Robson MD, Hawkins PN, Neubauer S, Moon JC, J Am Coll Cardiol Cardiovasc Imaging 2013 6 488 97 10.1016/j.jcmg.2012.11.013
36. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. Moon J, Messroghli D, Kellman P, Piechnik S, Robson M, Ugander M, Gatehouse P, Arai A, Friedrich M, Neubauer S, Schulz-Menger J, Schelbert E, J Cardiovasc Magn Reson 2013 15 92 10.1186/1532-429X-15-92 24124732
37. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials. Liu S, Han J, Nacif MS, Jones J, Kawel N, Kellman P, Sibley CT, Buemke DA, J Cardiovasc Magn Reson 2012 14 90 10.1186/1532-429X-14-90 23272704
38. Association between expansion of extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA, Shakesprere J, Kellman P, Shroff SG, Schwartzman DS, Mulukutla SR, Simon MA, Schelbert EB, Circulation 2012 126 1206 16 10.1161/CIRCULATIONAHA.111.089409 22851543
39. Diastolic abnormalities in systemic sclerosis: evidence for associated defective cardiac function reserve. Valentini G, Vitale DF, Giunta A, Malone S, Gerundo G, Arnese M, Tirri E, Pelaggi N, Giacummo A, Tirri G, Condorelli M, Ann Rheum Dis 1996 55 455 60 10.1136/ard.55.7.455 8774164
40. Assessment of nonischemic myocardial fibrosis. Jellis C, Martin J, Narula J, Marwick TH, J Am Coll Cardiol 2010 56 89 97 10.1016/j.jacc.2010.02.047 20620723
41. Influence of myocardial fibrosis on left ventricular diastolic function: noninvasive assessment by cardiac magnetic resonance and echo. Moreo A, Ambrosio G, de Chiara B, Pu M, Tran T, Mauri F, Raman SV, Circ Cardiovasc Imaging 2009 2 437 43 19920041
42. Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH, Circulation 2004 110 558 65 10.1161/01.CIR.0000138680.89536.A9 15277317
43. Tissue inhibitor of metalloproteinase-1 is a marker of diastolic dysfunction using tissue Doppler in patients with type 2 diabetes and hypertension. Tayebjee MH, Lim HS, Nadar S, MacFayden RJ, Lip GY, Eur J Clin Invest 2005 35 8 12 10.1111/j.1365-2362.2005.01438.x 15638813
44. Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. Knobelsdorff-Brenkenhoff F, Prothmann M, Dieringer M, Wassmuth R, Greiser A, Schwenke C, Niendorf T, Schulz-Menger J, J Cardiovasc Magn Reson 2013 15 53 10.1186/1532-429X-15-53 23777327
45. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Thavendiranathan P, Walls M, Giri S, Verhaert D, Rajagopalan S, Moore S, Simonetti OP, Raman SV, Circ Cardiovasc Imaging 2011 5 102 10 22038988